Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Rheumatology · Protracted Febrile Myalgia Syndrome

What is Protracted Febrile Myalgia Syndrome (PFMS)?

At a Glance

Protracted Febrile Myalgia Syndrome (PFMS) is a rare complication of Familial Mediterranean fever (FMF) that causes severe, paralyzing muscle pain and high fever lasting 2 to 6 weeks. Unlike typical FMF attacks, PFMS requires aggressive treatment like corticosteroids or IL-1 inhibitors.

If you are used to the typical 1- to 3-day attacks of Familial Mediterranean fever (FMF) and are suddenly experiencing severe, paralyzing muscle pain that lasts for weeks, you may be experiencing a rare but recognized complication called Protracted Febrile Myalgia Syndrome (PFMS) [1]. Unlike classic FMF flares that pass relatively quickly, a PFMS episode can persist for two to six weeks if left untreated [1][2]. It is characterized by severe, crippling muscle pain—often in the legs—along with a high fever [3][4]. While terrifying to experience, PFMS is a known condition with specific treatments available [5][1]. If you are currently experiencing these prolonged, agonizing symptoms, do not wait for them to pass naturally; seek immediate medical care from your rheumatologist or an emergency department.

How PFMS Differs from a Classic FMF Attack

A standard FMF attack usually lasts between 12 and 72 hours (one to three days) and often involves abdominal, chest, or joint pain [5]. In contrast, PFMS behaves differently and is considered a type of inflammatory condition affecting the muscles and fascia (the connective tissue surrounding muscles) [6].

The hallmark differences include:

  • Duration: PFMS lasts for weeks (usually 2 to 6 weeks) rather than just a few days [1][2].
  • Intensity of Pain: The muscle pain (myalgia) is incredibly severe. Patients often describe it as paralyzing or crippling, making it difficult or impossible to walk or move normally [1][3].
  • Location: While it can affect any muscle group, the severe pain is most commonly felt in the legs [3].
  • Accompanied by High Fever: The prolonged muscle pain is typically paired with a prolonged high-grade fever, though fever is occasionally absent [1][7].

Who is Most at Risk?

PFMS is a rare complication of FMF, but it is strongly associated with specific genetics [1][3]. Patients who carry the M694V mutation in their MEFV gene—particularly those who are homozygous (having two copies of the mutation)—are at a significantly higher risk for developing PFMS and experiencing more severe musculoskeletal symptoms [1][8][9]. In some cases, environmental triggers like a streptococcal infection can precipitate an episode of PFMS [10]. In rare instances, PFMS can even be the very first symptom someone experiences before they are officially diagnosed with FMF [1][11].

Diagnosis and Advocating for Your Care

Because PFMS is rare, an emergency room doctor or primary care provider might not immediately suspect it and could mistake your symptoms for a generic infection or muscle strain. You may need to proactively advocate for yourself by mentioning this specific FMF complication.

A key clinical finding in PFMS is that while your blood tests will show markedly elevated acute phase reactants (markers of widespread inflammation like ESR and CRP), your CPK (creatine phosphokinase, an enzyme that normally rises when muscle tissue is damaged) usually remains completely normal [1][12][2]. You can specifically ask your doctor to check these lab values. Your care team may also use an MRI of the affected limbs (such as your legs) to check for inflammation in the muscles or surrounding tissues [12].

Treatment Strategies

Treating PFMS looks drastically different from managing a standard FMF attack:

  • Corticosteroids: While standard NSAIDs (like ibuprofen) might take the edge off minor FMF pain, PFMS usually requires aggressive treatment with high-dose corticosteroids to bring the severe inflammation under control [1][5].
  • IL-1 Inhibitors: In cases where steroids do not completely abort the episode or the condition is resistant, biologic medications that block interleukin-1 (IL-1), such as anakinra or canakinumab, have been shown to provide dramatic relief [5][13][14].
  • Colchicine Management: Patients with the homozygous M694V mutation who develop PFMS sometimes show resistance to colchicine [8][9]. However, do not stop taking your daily colchicine without consulting your doctor, even if it feels like it is not currently stopping your symptoms. Your specialist will help you manage all of your medications during a flare.

Common questions in this guide

How long does a Protracted Febrile Myalgia Syndrome (PFMS) attack last?
Unlike a classic FMF attack that typically passes in one to three days, a PFMS episode can persist for two to six weeks if it is left untreated. It requires immediate medical attention from a rheumatologist or emergency department to manage the prolonged inflammation.
What does a PFMS attack feel like?
The primary symptoms are severe, crippling muscle pain, most commonly felt in the legs, along with a prolonged high-grade fever. Patients often describe the pain as paralyzing, making it incredibly difficult to walk or move normally.
How do doctors diagnose PFMS instead of a regular muscle strain?
Doctors can help diagnose PFMS by running specific blood tests. While markers for widespread inflammation like ESR and CRP will be markedly elevated, your CPK level, which normally rises when muscle tissue is damaged, will usually remain completely normal.
How is Protracted Febrile Myalgia Syndrome treated?
PFMS usually requires aggressive treatment to bring the severe inflammation under control. This typically involves high-dose corticosteroids or biologic medications that block interleukin-1 (IL-1), such as anakinra or canakinumab, to provide rapid relief.
Am I at a higher risk for PFMS if I have the M694V mutation?
Yes, having two copies of the M694V mutation in your MEFV gene puts you at a significantly higher risk for developing PFMS. Environmental triggers, such as a recent streptococcal infection, can also precipitate an attack in at-risk individuals.

Questions for Your Doctor

6 questions

  • Given my history with FMF and the fact that my severe muscle pain has lasted for weeks, could we investigate Protracted Febrile Myalgia Syndrome (PFMS) as a potential diagnosis?
  • Could we run blood tests to check my inflammatory markers (ESR, CRP) alongside my muscle enzyme (CPK) levels to look for the classic PFMS pattern?
  • Would ordering an MRI of my legs be useful to look for inflammation in my muscles and connective tissue?
  • Given the paralyzing severity of this flare, would high-dose corticosteroids or an IL-1 inhibitor like anakinra be an appropriate treatment plan to gain rapid control?
  • Do I carry the M694V mutation, and does that mean we should adjust my long-term strategy for preventing these severe musculoskeletal attacks?
  • How should I handle my daily colchicine dose during this prolonged episode, given that it doesn't seem to be stopping the current attack?

Questions for You

4 questions

  • Exactly how many days or weeks have I been experiencing this current bout of severe muscle pain and fever?
  • Does this pain feel paralyzing and completely different from the shorter joint or abdominal pain I experience during a typical FMF attack?
  • Have I recently had any infections, such as strep throat, that might have acted as a trigger for this severe flare?
  • Have I stopped or changed my daily colchicine dose out of frustration, and if so, have I communicated this to my medical care team?

References

References (14)
  1. 1

    Protracted febrile myalgia as a first and challenging manifestation of familial Mediterranean fever.

    Arslanoglu Aydin E, Baglan E, Bagrul I, et al.

    Modern rheumatology 2023; (33(5)):1030-1035 doi:10.1093/mr/roac087.

    PMID: 35920385
  2. 2

    Characterizing Protracted Febrile Myalgia: Fasciitis and Vasculitis of the Fascia and Muscle as Novel Histopathological Features.

    Hernández-Rodríguez J, Mestre-Trabal L, Gómez-Caverzaschi V, et al.

    Journal of clinical medicine 2024; (13(24)) doi:10.3390/jcm13247630.

    PMID: 39768554
  3. 3

    Corticosteroid-resistant anakinra-responsive protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever.

    Cakan M, Karadag SG, Ayaz NA

    Northern clinics of Istanbul 2020; (7(1)):78-80 doi:10.14744/nci.2019.38243.

    PMID: 32232210
  4. 4

    Protracted febrile myalgia syndrome in children with familial Mediterranean fever - systematic review and a case report.

    Hospach T, Blankenburg F, Heinkele A, et al.

    Pediatric rheumatology online journal 2024; (22(1)):85 doi:10.1186/s12969-024-01019-6.

    PMID: 39256780
  5. 5

    Protracted febrile myalgia as a challenging manifestation of familial Mediterranean fever: case-based review.

    Yıldırım DG, Bakkaloglu SA, Buyan N

    Rheumatology international 2019; (39(1)):147-152 doi:10.1007/s00296-018-4163-5.

    PMID: 30293156
  6. 6

    Polyarteritis nodosa in case of familial Mediterranean fever.

    Gökçe İ, Altuntaş Ü, Filinte D, Alpay H

    The Turkish journal of pediatrics 2018; (60(3)):326-330.

    PMID: 30511549
  7. 7

    Protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever in children: case-based review.

    Öztürk K, Çakan M

    Rheumatology international 2021; (41(1)):213-218 doi:10.1007/s00296-020-04696-0.

    PMID: 32895731
  8. 8

    The impact of homozygous mutations in exon 10 on musculoskeletal findings in children with familial mediterranean fever.

    Ozbakir C, Altug Gucenmez O

    European journal of pediatrics 2025; (184(10)):620 doi:10.1007/s00431-025-06478-x.

    PMID: 40958056
  9. 9

    The effect of gene dosage and age at the disease onset on the severity of familial Mediterranean fever.

    Polat MC, Çelikel E, Ekici Tekin Z, et al.

    Postgraduate medicine 2025; (137(1)):60-67 doi:10.1080/00325481.2024.2444870.

    PMID: 39693255
  10. 10

    Unusual presentation of familial Mediterranean fever with co-existing polyarteritis nodosa and acute post-streptococcal glomerulonephritis.

    Özdemir Atikel Y, Derinkuyu BE, Bakkaloğlu SA

    Clinical case reports 2022; (10(7)):e6022 doi:10.1002/ccr3.6022.

    PMID: 35898740
  11. 11

    Preliminary Evaluation for the Development of a Scoring System to Predict Homozygous M694V Genotype in Familial Mediterranean Fever Patients: A Single-Center Study.

    Tunce E, Uçar SA, Coşkuner T, et al.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2025; (31(1)):7-11 doi:10.1097/RHU.0000000000002165.

    PMID: 39705124
  12. 12

    Magnetic resonance findings may aid in diagnosis of protracted febrile myalgia syndrome: a retrospective, multicenter study.

    Aviran N, Amarilyo G, Lakovsky Y, et al.

    Orphanet journal of rare diseases 2022; (17(1)):15 doi:10.1186/s13023-021-02155-y.

    PMID: 35012585
  13. 13

    Protracted febrile myalgia syndrome treated with pulse of corticosteroids.

    Rom E, Amarilyo G, Levinski Y, et al.

    Seminars in arthritis and rheumatism 2018; (47(6)):897-899 doi:10.1016/j.semarthrit.2017.10.008.

    PMID: 29129325
  14. 14

    Protracted Febrile Myalgia Syndrome: A Rare and Difficult Manifestation of Familial Mediterranean Fever.

    Tunce E, Ulu K, Taşar S, Sözeri B

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2024; (30(7)):291-296 doi:10.1097/RHU.0000000000002125.

    PMID: 39271205

This page provides educational information about Protracted Febrile Myalgia Syndrome (PFMS) in FMF. It is not medical advice. Always consult your rheumatologist or visit an emergency room if you experience unusually severe or prolonged FMF symptoms.

Get notified when new evidence is published on Familial Mediterranean fever.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.